SPRB - Spruce Biosciences, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
105.0 2.27 (2.16%) 0.08 (0.07%) 0.31 (0.29%) -0.1 (-0.09%) -3.0 (-2.86%) 6.17 (6.1%) -3.25 (-3.09%) -3.3 (-3.13%)

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.32
Diluted EPS:
-0.32
Basic P/E:
-335.2188
Diluted P/E:
-335.2188
RSI(14) 1m:
55.88
VWAP:
107.21
RVol:

Events

Period Kind Movement Occurred At

Related News